Serum Interleukin-13 and Caspase 8 are Elevated in Prurigo Nodularis
DOI:
https://doi.org/10.2340/actadv.v103.4804Keywords:
inflammation, itch, proteomics, prurigo nodularis, pruritusAbstract
Abstract is missing (Short communication)
Downloads
References
Ingrasci G, Lipman ZM, Hawash AA, Girolomoni G, Yosipovitch G. The pruritogenic role of the type 2 immune response in diseases associated with chronic itch. Exp Dermatol 2021; 30: 1208-1217.
https://doi.org/10.1111/exd.14401 DOI: https://doi.org/10.1111/exd.14401
Mikhaylov D, Del Duca E, Guttman-Yassky E. Proteomic signatures of inflammatory skin diseases: a focus on atopic dermatitis. Expert Rev Proteomics 2021; 18: 345-361.
https://doi.org/10.1080/14789450.2021.1935247 DOI: https://doi.org/10.1080/14789450.2021.1935247
Engle SM, Chang CY, Ulrich BJ, Satterwhite A, Hayes T, Robling K, et al. Predictive biomarker modeling of pediatric atopic dermatitis severity based on longitudinal serum collection. Clin Exp Immunol 2021; 207: 253-262.
https://doi.org/10.1093/cei/uxab009 DOI: https://doi.org/10.1093/cei/uxab009
Belzberg M, Alphonse MP, Brown I, Williams KA, Khanna R, Ho B, et al. Prurigo nodularis is characterized by systemic and cutaneous T helper 22 immune polarization. J Invest Dermatol 2021; 141: 2208-2218.e14.
https://doi.org/10.1016/j.jid.2021.02.749 DOI: https://doi.org/10.1016/j.jid.2021.02.749
Tsoi LC, Hacini-Rachinel F, Fogel P, Rousseau F, Xing X, Patrick MT, et al., Transcriptomic characterization of prurigo nodularis and the therapeutic response to nemolizumab. J Allergy Clin Immunol 2022; 149: 1329-1339.
https://doi.org/10.1016/j.jaci.2021.10.004 DOI: https://doi.org/10.1016/j.jaci.2021.10.004
Miron Y, Miller PE, Hughes C, Indersmitten T, Lerner EA, Cevikbas F. Mechanistic insights into the antipruritic effects of lebrikizumab, an anti-IL-13 mAb. J Allergy Clin Immunol 2022; 150: 690-700.
https://doi.org/10.1016/j.jaci.2022.01.028 DOI: https://doi.org/10.1016/j.jaci.2022.01.028
Han JH, Park J, Kang TB, Lee KH. Regulation of caspase-8 activity at the crossroads of pro-inflammation and anti-inflammation. Int J Mol Sci 2021; 22: 3318.
https://doi.org/10.3390/ijms22073318 DOI: https://doi.org/10.3390/ijms22073318
Williams KA, Huang AH, Belzberg M, Kwatra SG. Prurigo nodularis: pathogenesis and management. J Am Acad Dermatol 2020; 83: 1567-1575.
https://doi.org/10.1016/j.jaad.2020.04.182 DOI: https://doi.org/10.1016/j.jaad.2020.04.182
Brembilla NC, Senra L, Boehncke WH. The IL-17 family of cytokines in psoriasis: IL-17A and beyond. Front Immunol 2018; 9: 1682.
https://doi.org/10.3389/fimmu.2018.01682 DOI: https://doi.org/10.3389/fimmu.2018.01682
Gholibeigian Z, Izad M, Daneshpazhooh M, Mortazavi H, Salehi Z, Behruzifar S, Akhdar, et al. Decreased serum levels of interleukin-17, interleukin-23, TGF-β in pemphigus vulgaris patients, and their association with disease phase. Dermatol Ther 2020; 33: e14071.
https://doi.org/10.1111/dth.14071 DOI: https://doi.org/10.1111/dth.14071
Aşkın Ö, Yücesoy SN, Coşkun E, Engin B, Serdaroğlu S. Evaluation of the level of serum interleukins (IL-2, IL-4, IL-15 andIL-17) and its relationship with disease severity in patients with alopecia areata. An Bras Dermatol 2021; 96: 551-557.
https://doi.org/10.1016/j.abd.2021.03.006 DOI: https://doi.org/10.1016/j.abd.2021.03.006
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2023 Teresa Ju, Angelina Labib, Leigh Nattkemper, Sarah Engle, Autum Auxier, Nathan Hahn, Sean Sissons, Jonathan T. Sims, Zhe Sun, Angela J. Okragly, Gil Yosipovitch
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.